A low-lying upper eyelid can make one or both eyes look tired, uneven, or less open—and for some adults, it can also affect the upper field of vision. Upneeq offers an FDA-approved prescription eye-drop option for appropriate adults with acquired ptosis.
At Body BeneFits in The Woodlands, your visit begins with an eyelid and health assessment. If Upneeq is appropriate, you receive clear instructions for convenient once-daily use, realistic expectations, and provider-guided follow-up.
Upneeq is a prescription ophthalmic solution containing oxymetazoline hydrochloride 0.1%. It is FDA approved for acquired blepharoptosis, also called acquired low-lying upper eyelid, in adults.
In an appropriate patient, the medication activates a small upper-eyelid muscle to create a temporary lift while the drop is active. The prescribed dose is generally one drop in each affected eye once daily. Some patients notice a more open-looking upper eyelid the same day, although the amount of lift, symmetry, timing, and duration vary.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The visit begins with a review of the eyelid position, onset and pattern of drooping, vision concerns, eye history, medical conditions, medications, and symptoms that may point to another cause. Photography or referral to an optometrist, ophthalmologist, or other clinician may be recommended before a prescription is considered.
If Upneeq is appropriate, use one prescribed drop in each affected eye once daily. Some patients notice a lift the same day, but the amount and duration are variable and daily use does not create a permanent structural change. Do not use extra drops to chase a stronger or longer result.
Possible adverse reactions include eye irritation or pain, redness, dryness, blurred vision, punctate keratitis, and headache. Seek urgent medical care for severe eye pain, halos or sudden vision change, marked headache, nausea, sudden or worsening droop, double vision, unequal pupils, weakness, trouble speaking, or another concerning neurologic symptom.
We review onset, eyelid position, vision symptoms, eye history, and warning signs to confirm whether prescription care or referral is appropriate.
Health conditions, blood pressure, glaucoma risk, eye drops, and potentially interacting medicines are reviewed before prescribing.
Learn single-use vial hygiene, prescribed dosing, contact-lens timing, and separation from other topical eye medications.
Track eyelid lift, symmetry, comfort, vision, and duration, and promptly report severe eye or neurologic symptoms.
Upneeq may be considered for an adult with acquired upper-eyelid ptosis when the prescribing provider determines that the condition and health history are appropriate for medical drop therapy. It may be useful for patients seeking a nonsurgical, temporary lift or a trial of symptom improvement, but it does not remove excess skin and will not address every eyelid or eyebrow concern.
Tell the provider about high or low blood pressure, cardiovascular or cerebrovascular disease, circulation problems, glaucoma or narrow-angle risk, eye injury or surgery, dry-eye or corneal disease, pregnancy or breastfeeding, and all prescription, nonprescription, and ophthalmic medications. Important medication review may include blood-pressure drugs, beta-blockers, cardiac glycosides, alpha-adrenergic antagonists, and monoamine oxidase inhibitors. Do not stop or change a prescribed medicine without the prescribing clinician.
New, sudden, painful, one-sided, fluctuating, or progressively worsening ptosis should not be treated as a cosmetic issue without appropriate evaluation. Children and people whose droop is congenital or caused by another untreated condition require care directed by the appropriate specialist.
Body BeneFits offers provider-supervised Upneeq consultations for appropriate adults in The Woodlands and nearby communities. The goal is to determine whether prescription eye drops are reasonable, whether another aesthetic or surgical approach better matches the concern, or whether an eye-care or medical referral should come first.
Upneeq works only while the medication is active and is generally used daily as prescribed. Eyelid lift, symmetry, visual-field improvement, onset, and duration differ by patient and by the underlying cause of ptosis. Follow-up helps assess benefit, tolerability, correct technique, and whether continued treatment remains appropriate. No specific amount of lift or permanent result can be guaranteed.
Contact Body BeneFits in The Woodlands to discuss acquired low-lying upper eyelids and whether prescription Upneeq may be appropriate. Your consultation includes eyelid and symptom review, medication and health screening, realistic expectations, use instructions, and referral guidance when another evaluation is needed.
Upneeq is FDA approved to treat acquired blepharoptosis, or acquired low-lying upper eyelid, in adults. It is available by prescription after a provider determines that the eyelid concern and health history are appropriate for treatment.
Upneeq contains oxymetazoline hydrochloride 0.1%, an alpha-adrenergic agonist that activates a small upper-eyelid muscle. In an appropriate patient, this can create a temporary lift while the medication is active.
Some patients notice a change the same day. The onset, amount of lift, symmetry, visual-field response, and duration vary by person and by the underlying cause of the eyelid position.
Use the medication exactly as prescribed, generally one drop in each affected eye once daily. Remove contact lenses before use and wait at least 15 minutes before reinserting them. Separate other topical eye medications by at least 15 minutes unless your prescriber directs otherwise.
No. Upneeq works temporarily while the medication is active. It does not remove excess eyelid skin, permanently change eyelid structure, replace surgery when surgery is indicated, or treat every cause of ptosis.
Possible reactions include eye irritation or pain, redness, dryness, blurred vision, headache, and discomfort when the drop is applied. Contact your prescriber promptly about concerning, persistent, severe, or worsening symptoms.
Upneeq (oxymetazoline hydrochloride ophthalmic solution) 0.1% is a prescription medication for acquired blepharoptosis in adults. It is not appropriate for every cause of eyelid drooping and does not replace evaluation by an optometrist, ophthalmologist, or other qualified medical professional when indicated. Sudden eyelid drooping—especially with unequal pupils, double vision, severe headache, facial weakness, limb weakness, speech changes, or other neurologic symptoms—requires urgent medical evaluation. Tell your prescriber about high or low blood pressure; cardiovascular, cerebrovascular, or circulation disorders; glaucoma or narrow-angle risk; eye injury, surgery, dry eye, or corneal disease; pregnancy or breastfeeding; and all prescription, nonprescription, and ophthalmic medications. Alpha-adrenergic agonists may affect blood pressure and may interact with antihypertensives, cardiac medications, beta blockers, monoamine oxidase inhibitors, tricyclic antidepressants, and other drugs. Upneeq may increase the risk of angle-closure glaucoma in susceptible patients. Use only as prescribed. Individual response and tolerability vary, and no amount or duration of eyelid lift, visual improvement, symmetry, or permanent result is guaranteed.
